SMH
·general
·1 hour ago
Perth biotech Syngenis unleashes AI drug discovery push
Perth-based Syngenis Laboratories launched an AI-powered drug discovery platform designed to compress molecular screening from months into hours. The system analyzes billions of genetic sequences from databases like the National Center for Biotechnology Information to identify viable treatments. The platform targets oligonucleotide therapeutics, a rapidly growing RNA and DNA-based medicine sector boosted by mRNA vaccine success during the COVID-19 pandemic.
Summary by Glance · SMH
Newer
Next
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI